DOCUMENT
65 -- Labetolol Tablets (VA-18-919316) - Attachment
- Notice Date
- 11/16/2017
- Notice Type
- Attachment
- NAICS
- 325412
— Pharmaceutical Preparation Manufacturing
- Contracting Office
- VA National Acquisition Center - Department of Veterans Affairs National Acquisition Center
- Solicitation Number
- 36E79718R0011
- Response Due
- 12/19/2017
- Archive Date
- 3/28/2018
- Point of Contact
- Richard Mahario
- E-Mail Address
-
6-5247<br
- Small Business Set-Aside
- N/A
- Description
- Page 1 of 1 PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79718R0011 for an unrestricted procurement for Labetalol Tablets, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). Award will be made to the responsible contractor(s) per individual product group or a combination of product groups if this results in the lowest overall price to the Government. To be considered for award, offerors must propose prices for all line items for the base and each option year for all items within a product group or groups proposed. Line items 1, 2, 3, 4, and 5. The period of contract will be for one year plus four one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Solicitation # 36E79718R0011 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about December 4, 2017, with a tentative closing date of December 19, 2017. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. Offers will be considered technically acceptable if the meet the following criteria: 1) NDC must be unique to the offeror, 2) Drug must be FDA approved, 3) Manufacturing facility must have an acceptable current Good Manufacturing Practices rating by FDA. 4) Offeror must meet the estimated annual requirements as listed below. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Richard Mahario. Questions can be e-mailed to: Richard.Mahario@va.gov The estimated annual requirements are as follows: Description Size Estimated Annual Requirements Labetalol HCL 100MG Bottles of 100 Tablets 26,864 Labetalol HCL 100MG Bottles of 500 Tablets 2,785 Labetalol HCL 200MG Bottles of 100 Tablets 19,889 Labetalol HCL 200MG Bottles of 500 Tablets 9,681 Labetalol HCL 300MG Bottles of 100 Tablets 20,544
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/VA/VANAC/VANAC/36E79718R0011/listing.html)
- Document(s)
- Attachment
- File Name: 36E79718R0011 36E79718R0011_1.docx (https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=3911543&FileName=36E79718R0011-000.docx)
- Link: https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=3911543&FileName=36E79718R0011-000.docx
- Note: If links are broken, refer to Point of Contact above or contact the FBO Help Desk at 877-472-3779.
- File Name: 36E79718R0011 36E79718R0011_1.docx (https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=3911543&FileName=36E79718R0011-000.docx)
- Record
- SN04742420-W 20171118/171116231130-045975ae7aa022cafc246f8300e7eb2c (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |